Dai Mouri

Phase I trial of gemcitabine and candesartan combination therapy in normotensive patients with advanced pancreatic cancer: GECA1

N. Sasahira, K. Koike, H. Ijichi, 2012, Cancer science.

A Multicenter Open-Label Randomized Controlled Trial of Pancreatic Enzyme Replacement Therapy in Unresectable Pancreatic Cancer

K. Koike, Tomotaka Saito, Y. Nakai, 2018, Pancreas.

Fluid sequestration is a useful parameter in the early identification of severe disease of acute pancreatitis

K. Koike, Tomotaka Saito, Y. Nakai, 2018, Journal of Gastroenterology.